Latest Articles
'It felt like someone was twisting and stabbing my organs — doctors dismissed me' - Express.co.uk
'It felt like someone was twisting and stabbing my organs — doctors dismissed me' Express.co.uk
Published: March 2, 2026, 6:01 a.m.
'It felt like someone was twisting and stabbing my organs — doctors dismissed me' - Daily Express
'It felt like someone was twisting and stabbing my organs — doctors dismissed me' Daily Express
Published: March 2, 2026, 6:01 a.m.
Scots women ‘waiting decade for endometriosis diagnosis’ - PressReader
Scots women ‘waiting decade for endometriosis diagnosis’ PressReader
Published: March 2, 2026, 5:58 a.m.
ENDOMETRIOSIS explained - PressReader
ENDOMETRIOSIS explained PressReader
Published: March 1, 2026, 2:05 p.m.
Britain BAFTA Film Awards 2026 Winners Photo Call - The Argus-Press
Britain BAFTA Film Awards 2026 Winners Photo Call The Argus-Press
Published: March 1, 2026, 1:29 p.m.
Endometriosis Action Month: Doncaster mum opens up on battle with excruciating condition - Doncaster Free Press
Endometriosis Action Month: Doncaster mum opens up on battle with excruciating condition Doncaster Free Press
Published: March 1, 2026, 6 a.m.
Dire shortage of healthcare providers capable of performing potentially life-changing endometriosis scans - 9News.com.au
Dire shortage of healthcare providers capable of performing potentially life-changing endometriosis scans 9News.com.au
Published: Feb. 28, 2026, 7:32 p.m.
'I felt pressured into borrowing £7,000 to freeze my eggs privately' - STV News
'I felt pressured into borrowing £7,000 to freeze my eggs privately' STV News
Published: Feb. 28, 2026, 11:25 a.m.
ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon - TipRanks
ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon TipRanks
Published: Feb. 27, 2026, 7:47 p.m.
ACRV: ACR-368 delivers strong efficacy and safety in serous endometrial cancer, advancing toward approval - TradingView
ACRV: ACR-368 delivers strong efficacy and safety in serous endometrial cancer, advancing toward approval TradingView
Published: Feb. 27, 2026, 3:34 p.m.
Link copied to clipboard!